Ruoxiang Wang
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Cells and Metastasis
- Bone health and treatments
Papers in
-
- Cell death mechanisms and regulation 7
- Bone Metabolism and Diseases 7
- Ubiquitin and proteasome pathways 7
- Oncology 39
- Cancer Cells and Metastasis 19
- Bone health and treatments 11
- Co-authors
- Haiyen E. Zhau (48 shared papers)Leland W.K. Chung (43 shared papers)Fray F. Marshall (13 shared papers)Yufang Shi (7 shared papers)Jianchun Xu (8 shared papers)Gina Chia‐Yi Chu (14 shared papers)Xiaojian Yang (4 shared papers)Nicola J. Mabjeesh (5 shared papers)
- Journals
- The Prostate (8 papers)Cancer Research (8 papers)PLoS ONE (5 papers)Clinical Cancer Research (4 papers)The Journal of Urology (4 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Ruoxiang Wang
82 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 126
- Cancer Research 777
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 904
- Molecular Biology 1.6k
- Cell Biology 229
Countries citing papers authored by Ruoxiang Wang
This map shows the geographic impact of Ruoxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruoxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruoxiang Wang more than expected).
Fields of papers citing papers by Ruoxiang Wang
This network shows the impact of papers produced by Ruoxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruoxiang Wang. The network helps show where Ruoxiang Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruoxiang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 259 | |
| 2 | 1997 | 143 | |
| 3 | 2008 | 124 | |
| 4 | 2006 | 115 | |
| 5 | 2009 | 111 | |
| 6 | 2008 | 111 | |
| 7 | 2002 | 95 | |
| 8 | 2004 | 95 | |
| 9 | 2010 | 92 | |
| 10 | 2011 | 90 | |
| 11 | 2014 | 87 | |
| 12 | 2005 | 82 | |
| 13 | 2006 | 77 | |
| 14 | 2012 | 77 | |
| 15 | 2002 | 69 | |
| 16 | 2014 | 68 | |
| 17 | 2014 | 63 | |
| 18 | 2006 | 60 | |
| 19 | 2016 | 58 | |
| 20 | 1998 | 57 |
About Ruoxiang Wang
Ruoxiang Wang is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 86 papers that have together received 3.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (23 papers), Cancer Cells and Metastasis (19 papers), Cancer, Hypoxia, and Metabolism (13 papers), Bone health and treatments (11 papers), Cell death mechanisms and regulation (7 papers), Bone Metabolism and Diseases (7 papers), Ubiquitin and proteasome pathways (7 papers) and Nanoplatforms for cancer theranostics (6 papers). The work is most often cited by research in Cancer Research (777 citations), Oncology (1.1k citations), Pulmonary and Respiratory Medicine (904 citations), Molecular Biology (1.6k citations) and Cell Biology (229 citations). Ruoxiang Wang has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Haiyen E. Zhau, Leland W.K. Chung, Fray F. Marshall, Yufang Shi, Jianchun Xu, Gina Chia‐Yi Chu, Xiaojian Yang, Nicola J. Mabjeesh, Chunmeng Shi and Peizhen Hu. Their work appears in journals such as The Prostate, Cancer Research, PLoS ONE, Clinical Cancer Research and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.